Targeted Therapy Directed by Genetic Testing in Treating Patients With Advanced Refractory Solid Tumors, Lymphomas, or Multiple Myeloma (The MATCH Screening Trial)
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Carevive Systems, Inc.
Royal Marsden NHS Foundation Trust
Ohio State University Comprehensive Cancer Center
Mayo Clinic
Washington University School of Medicine
Compugen Ltd
Cedars-Sinai Medical Center
Cedars-Sinai Medical Center
Centre Hospitalier Henri Duffaut - Avignon
Incyte Corporation
Celgene
InSightec
University of Wisconsin, Madison
Shenzhen BinDeBio Ltd.
Amgen
Alliance for Clinical Trials in Oncology
Ohio State University Comprehensive Cancer Center
Shenzhen Second People's Hospital
Alliance for Clinical Trials in Oncology
National Cancer Institute (NCI)
National Cancer Institute (NCI)
AstraZeneca
Amgen